InvaGen Pharmaceuticals, Inc. → AVENUE THERAPEUTICS, INC. ATXI

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

5,290 shares short · +735.7% vs prior

Other 13D/G Filings on AVENUE THERAPEUTICS, INC.

Filed	Form	Filer	Stake	Shares
2026-01-06	SCHEDULE	Fortress Biotech, Inc.	13.40%	439,955	view →
2025-04-02	SCHEDULE	Fortress Biotech, Inc.	10.30%	328,746	view →
2025-01-03	SCHEDULE	Fortress Biotech, Inc.	13.80%	295,022	view →
2024-01-02	SC	SABBY MANAGEMENT, LLC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →